Watch the Elligo Elite Learning Series webinar for a discussion on how AI can enhance and accelerate almost every aspect of drug development and how researchers can implement this new technology in their research. The roundtable is hosted by Michael Ibara, Pharm.D., Chief Data Officer at Elligo Health Research® and features AI and research experts Paul Della Maggiora, CEO & CTO at Avallano and Enrique Garcia-Rivera, Ph.D., VP of AI at Bullfrog AI.